NURP 533 Test 1 Week 1 -3 Simmons University ACTUAL
EXAM APPROVED QUESTIONS AND CORRECT VERIFIED
ANSWERS WITH RATIONALES (A NEW UPDATED VERSION
2026) |GUARANTEED PASS A+ |FULL REVISED CESCP EXAM
2026-2027
The American Diabetes Association (2020) recommends screening
for diabetes in
adults of any age who are overweight or obese (BMI greater than 25
kg/m2) and have another risk factor (such as hypertension).4 For
those without additional risk factors, the BMI greater than 25 kg/m2
should only prompt screening for diabetes at age 45 years old or
older
According to the 2017 guidelines, for adults with confirmed
hypertension and known CVD or 10- year ASCD event risk greater
than or equal to 10%, a target of
<130/80 mm Hg is recommended. For those without additional
markers of increased CVD risk, a BP target < 130/80 mm Hg may be
reasonable.
,the recommended initial antihypertensive agents should include
thiazide-type diuretic, calcium channel blocker (CCB),
angiotensin-converting enzyme (ACE) inhibitor, or an angiotensin
II receptor blocker (ARB). ACE inhibitors and ARBs should not be
used in combination.
Remember, if there is a chance that the patient could become
pregnant, ACE inhibitors and ARBs are pregnancy category X.
tx for HTN + CHF
Thiazides, beta blockers, ACE inhibitors, ARBs, aldosterone antagonist
Tx for HTN + Post MI
Beta blockers, ACE inhibitors, aldosterone antagonist
tx for HTN + high CVD risk
Thiazides, beta blockers, ACE inhibitor, CCB
tx for HTN +DM
Thiazides, beta blockers, ACE inhibitor, ARB, CCB
tx for HTN + CKD
ACE inhibitor, ARB
,tx for HTN + Recurrent stroke prevention
Thiazides, ACE inhibitor
tx for HTN +BPH
Alpha blocker (generally not recommended for
HTN, but in patients with this condition, alpha blockers may be useful)
RF associated with dx of secondary HTN
Drug-resistant/induced hypertension, Abrupt onset of hypertension,
Onset of hypertension at age younger than 30 years old,
Exacerbation of previously controlled hypertension,
Accelerated/malignant hypertension, Onset of diastolic
hypertension in older adults (age older than 65 years old),
Unprovoked or excessive hypokalemia
how common is secondary HTN
secondary hypertension accounts for 5% to 10% of hypertension in
adults; secondary hypertension is much more common in the
(approximate) 10% of children who have hypertension.
, 10 causes of Secondary HTN
Apnea (OSA)
Aldosteronism (Primary hyperaldosteronism)
Bruits (Renovascular disease such as renal artery stenosis or
fibromuscular dysplasia)
Bad parenchymal disease (Chronic kidney disease)
Catecholamines (Pheochromocytoma, other catecholamine
release situations,
decongestants, herbal preparations)
Coarctation of the aorta
Cushing's syndrome and other excess glucocorticoid states
Drug induced or related
Diet (excess of sodium, alcohol, black licorice)
Erythropoietin excess (exogenous or secondary to
COPD/polycythemia) Endocrine disorders (not already listed):
hypothyroidism, hyperthyroidism, hyperparathyroidism, pregnancy-
induced hypertension, pheochromocytoma, acromegaly
EXAM APPROVED QUESTIONS AND CORRECT VERIFIED
ANSWERS WITH RATIONALES (A NEW UPDATED VERSION
2026) |GUARANTEED PASS A+ |FULL REVISED CESCP EXAM
2026-2027
The American Diabetes Association (2020) recommends screening
for diabetes in
adults of any age who are overweight or obese (BMI greater than 25
kg/m2) and have another risk factor (such as hypertension).4 For
those without additional risk factors, the BMI greater than 25 kg/m2
should only prompt screening for diabetes at age 45 years old or
older
According to the 2017 guidelines, for adults with confirmed
hypertension and known CVD or 10- year ASCD event risk greater
than or equal to 10%, a target of
<130/80 mm Hg is recommended. For those without additional
markers of increased CVD risk, a BP target < 130/80 mm Hg may be
reasonable.
,the recommended initial antihypertensive agents should include
thiazide-type diuretic, calcium channel blocker (CCB),
angiotensin-converting enzyme (ACE) inhibitor, or an angiotensin
II receptor blocker (ARB). ACE inhibitors and ARBs should not be
used in combination.
Remember, if there is a chance that the patient could become
pregnant, ACE inhibitors and ARBs are pregnancy category X.
tx for HTN + CHF
Thiazides, beta blockers, ACE inhibitors, ARBs, aldosterone antagonist
Tx for HTN + Post MI
Beta blockers, ACE inhibitors, aldosterone antagonist
tx for HTN + high CVD risk
Thiazides, beta blockers, ACE inhibitor, CCB
tx for HTN +DM
Thiazides, beta blockers, ACE inhibitor, ARB, CCB
tx for HTN + CKD
ACE inhibitor, ARB
,tx for HTN + Recurrent stroke prevention
Thiazides, ACE inhibitor
tx for HTN +BPH
Alpha blocker (generally not recommended for
HTN, but in patients with this condition, alpha blockers may be useful)
RF associated with dx of secondary HTN
Drug-resistant/induced hypertension, Abrupt onset of hypertension,
Onset of hypertension at age younger than 30 years old,
Exacerbation of previously controlled hypertension,
Accelerated/malignant hypertension, Onset of diastolic
hypertension in older adults (age older than 65 years old),
Unprovoked or excessive hypokalemia
how common is secondary HTN
secondary hypertension accounts for 5% to 10% of hypertension in
adults; secondary hypertension is much more common in the
(approximate) 10% of children who have hypertension.
, 10 causes of Secondary HTN
Apnea (OSA)
Aldosteronism (Primary hyperaldosteronism)
Bruits (Renovascular disease such as renal artery stenosis or
fibromuscular dysplasia)
Bad parenchymal disease (Chronic kidney disease)
Catecholamines (Pheochromocytoma, other catecholamine
release situations,
decongestants, herbal preparations)
Coarctation of the aorta
Cushing's syndrome and other excess glucocorticoid states
Drug induced or related
Diet (excess of sodium, alcohol, black licorice)
Erythropoietin excess (exogenous or secondary to
COPD/polycythemia) Endocrine disorders (not already listed):
hypothyroidism, hyperthyroidism, hyperparathyroidism, pregnancy-
induced hypertension, pheochromocytoma, acromegaly
